Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer

ClinicalTrials.gov ID: NCT02111577

Public ClinicalTrials.gov record NCT02111577. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 6:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Blind, Multicenter, Parallel-group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men With Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The VIABLE study sought to confirm the hypothesis that the combination of docetaxel with DCVAC/PCa followed by a maintenance therapy with DCVAC/PCa would improve overall survival in patients with metastatic castration-resistant prostate cancer.

Study identification

NCT ID
NCT02111577
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
SOTIO a.s.
Industry
Enrollment
1,182 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 26, 2014 (Actual)
Primary completion
Jan 28, 2020 (Actual)
Completion
Jan 28, 2020 (Actual)
Last update posted
Apr 6, 2021

2014 – 2020

United States locations

U.S. sites
58
U.S. states
28
U.S. cities
55
Facility City State ZIP Site status
University of South Alabama Mitchell Cancer Institute Mobile Alabama 36604 —
Ironwood Cancer & Research Centers Chandler Arizona 85224 —
Mayo Clinic Scottsdale Arizona 85259-5499 —
Compassionate Care Research Group, Inc. Corona California 92879 —
California Cancer Associates for Research and Excellence Encinitas California 92024 —
Compassionate Care Research Group, Inc. Fountain Valley California 92708 —
St. Joseph Heritage Healthcare Fullerton California 92835 —
Hao Wei Zhang, MD, LLC Los Angeles California 90033 —
Desert Hematology Oncology Medical Group Rancho Mirage California 92270 —
Compassionate Care Research Group, Inc. Riverside California 92501 —
Sharp Clinical Oncology Research San Diego California 92123 —
Oncology Institute of Hope and Innovation Whittier California 90603 —
Rocky Mountain Cancer Centers Aurora Colorado 80012 —
University of Colorado Aurora Colorado 80045 —
Yale Cancer Center New Haven Connecticut 06519 —
Eastern CT Hematology and Oncololgy Associates Norwich Connecticut 06360 —
Medstar Georgetown University Hospital Washington D.C. District of Columbia 20007 —
Univ. of Miami, Sylvester Comprehensive Cancer Center Miami Florida 33136 —
Winship Cancer Institute of Emory University Atlanta Georgia 30322 —
Saint Luke's Cancer Institute Kansas City Kansas 64111 —
University of Kansas Cancer Center & Medical Pavilion Westwood Kansas 66205 —
Tulane University New Orleans Louisiana 70112 —
University of Maryland Greenebaum Cancer Center Baltimore Maryland 21201 —
Associates In Oncology/Hematology,P.C Rockville Maryland 20850 —
Dana-Farber Cancer Institute Boston Massachusetts 02115 —
Umass Memorial Medical Center Worcester Massachusetts 01655 —
Henry Ford Health System Detroit Michigan 48202 —
Karmanos Cancer Center Detroit Michigan 48202 —
Minnesota Oncology Hematology, P.A. Minneapolis Minnesota 55404 —
GU Research Network Omaha Nebraska 68130 —
Nebraska Cancer Specialists Omaha Nebraska 68130 —
Comprehensive Cancer Research Centers of Nevada Henderson Nevada 89052 —
New Jersey Hematology Oncology Associates Brick New Jersey 08724 —
Premier Urology Associates, LLC / AdvanceMed Research Lawrenceville New Jersey 08648 —
Cancer Institute of New Jersey New Brunswick New Jersey 08901 —
Mount Sinai Medical Center New York New York 10029 —
SUNY Upstate Medical University Syracuse New York 13210 —
Montefiore Medical Center The Bronx New York 10467 —
UC Health University of Cincinnati Cincinnati Ohio 45267 —
Oregon Health & Science University Portland Oregon 97239 —
Northwest Cancer Specialists, P.C. Tualatin Oregon 97062 —
Urologic Consultants of Southeastern Pennsylvania Bala-Cynwyd Pennsylvania 19004 —
Cancer Care Associates St. Luke's University and Health Network Easton Pennsylvania 18045 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
UPMC Cancer Center Pittsburgh Pennsylvania 15232 —
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 —
Associates in Oncology & Hematology Chattanooga Tennessee 37421 —
Arlington Cancer Center Arlington Texas 76012 —
UT Health, Internal Medicine, Division of Oncology Houston Texas 77030 —
Texas Health Physicians Group Plano Texas 75093 —
Cancer Care Network of South Texas San Antonio Texas 78217 —
Tyler Hematology Oncology Tyler Texas 75701 —
Utah Cancer Specialists Salt Lake City Utah 84106 —
Fort Belvoir Community Hospital Fort Belvoir Virginia 22060 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Virginia Mason Medical Center Seattle Washington 98012 —
Northwest Medical Specialties, PLLC Tacoma Washington 98405 —
West Virginia University Mary Babb Randolph Cancer Center Morgantown West Virginia 26506 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 119 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02111577, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 6, 2021 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02111577 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →